drugset / Trial / NCT00708578
Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)
RandomizedParallel-groupOpen-labelTreatment
Summary
Primary objective: To find out an optimal regimen of OHA (oral hypoglycaemic agents) in combination with insulin glargine (metformin, glimepiride or metformin+glimepiride) by measuring HbA1c level Secondary objective: To compare the incidence of hypoglycemia in each treatment group
Timeline
- Start
- 2008-05
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glimepiride | Small molecule | 4 mg | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |
| Subject | Metformin | Small molecule | 1500 mg | Oral |
| Subject | insulin glargine | Protein / enzyme biologic | — | Other |